(FM) Oncología
Departamento académico
Yonsei University
Seúl, Corea del SurPublicacions en col·laboració amb investigadors/es de Yonsei University (2)
2024
-
Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial
Journal of Clinical Oncology, Vol. 42, Núm. 1, pp. 47-58
2019
-
The Combination of MEK Inhibitor With Immunomodulatory Antibodies Targeting Programmed Death 1 and Programmed Death Ligand 1 Results in Prolonged Survival in Kras/p53-Driven Lung Cancer
Journal of Thoracic Oncology, Vol. 14, Núm. 6, pp. 1046-1060